Intervention of a Digital Health Management Program in Patients With Cardiometabolic Disorders: a Real-world Study
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 300
- 试验地点
- 1
- 主要终点
- Changes in diastolic blood pressure after 24 weeks
研究概览
简要总结
The aim of this study is to construct a digital precision intervention system for cardiometabolism disorders based on the characteristics of the Chinese population, focusing on the core components of metabolic syndrome such as hypertension, hyperglycemia, and obesity. Through dynamic monitoring of wearable devices, the individualized risk factors (including genetic predisposition, lifestyle, and psychological factors) of metabolic disorders were systematically analyzed, and dynamic intervention strategies were formulated accordingly. The closed-loop management of "monitor-feedback-optimization" based on the digital platform will provide patients with one-stop metabolic risk assessment and panoramic health management plan, realizing a paradigm shift from "generalized intervention" to "precise regulation". By reducing the abnormal fluctuations of key metabolic indicators such as blood pressure, blood glucose, and blood lipids, the risk of cardiovascular events will eventually be reduced, the long-term quality of life of patients will be improved, and a practical path of "digital therapy" can be promoted for the prevention and control of chronic diseases in China
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 65 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age 18-65 years old;
- •Meet one of the following three conditions:
- •Diastolic hypertension (systolic blood pressure < 140 MMHG and diastolic blood pressure ≥90mmHg)
- •Glycosylated hemoglobin (6.0-6.5)
- •Obesity (BMI≥28kg/m²)
- •Mild hyperlipemia: total cholesterol (TC) ≥5.2 mmol/L and < 6.2 mmol/L, or low-density lipoprotein cholesterol (LDL-C) ≥3.4 mmol/L and < 4.1 mmol/L
- •Antihypertensive or lipid-lowering medications have not been started
- •Use a smartphone and volunteer
排除标准
- •Complicated with chronic liver and kidney disease, coronary heart disease, heart failure and severe valvular disease
- •Previous cardiovascular and cerebrovascular events
- •Diastolic blood pressure ≥99mmHg
- •Glycated hemoglobin ≥6.5
- •Other life expectancy such as cancer is less than 5 years
- •Participate in other clinical trials
研究组 & 干预措施
Cardiovascular digital management group
Participants used a bracelet and an APP assistant for lifestyle interventions
干预措施: Bracelet, assistant, APP: the "golden triangle" of smart life (Other)
结局指标
主要结局
Changes in diastolic blood pressure after 24 weeks
时间窗: 24 weeks following intervention
次要结局
- Values for changes in Hba1c or BMI or CAI after 24 weeks(24 weeks following intervention)
研究者
Ya-Wei Xu
professor of Medicine
Shanghai 10th People's Hospital
